Replies to post #20872 on $Bob's and Jbem's Bitchin' Bios

[porgyrusty]

Its from June, but I find it hard to believe that things have changed much.

What: Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharma focused on diseases of the central nervous system, were up more than 12% as of 3:30 p.m. ET on rumors that AstraZeneca PLC (ADR) (NYSE:AZN) is eyeing the company as a potential acquisition candidate.

So what: According to a report from the Daily Mail last Friday, pharma giant AstraZeneca is said to be one of the companies that is interested in placing a bid on ACADIA Pharmaceuticals. The report claims that Acadia would not even consider an offer of less than $60 per share, which is 50% higher than what shares are currently fetching.
http://www.fool.com/investing/general/2016/06/06/why-shares-of-acadia-pharmaceuticals-inc-jumped-to.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2